Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
logo icon CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Medicilon Events

Hot information:
Two Innovative Service Platforms of Medicilon were Selected as Shanghai International Service Trade Demonstration project| Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use| Receiving market recognition! Medicilon won the 2020 "Golden Bull Science and Technology Innovation Award"
Mar 10,2020
API Process Development of the New Drug IND Stage
In the development of innovative drugs, the progress of the process development of the IND phase of the API often directly affects the subsequent formulation
More
API Process Development of the New Drug IND Stage
Feb 02,2020
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
During the Spring Festival, China has been facing a difficult time as the coronavirus spread all over the country.  In order to stop the coronavirus,
More
Taking the Responsibility and Praying for the Peace; Medicilon helps to fight the coronavirus by providing funds and technology
Dec 24,2019
Warmest Holiday Season Greeting From Medicilon
Warmest Holiday Greetings to you and your families from Medicilon! As the end of year is approaching, we would like to express our sincere gratitude
More
Warmest Holiday Season Greeting From Medicilon
Dec 19,2019
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
On December 7, 2019, the 2019 annual meeting of the Biomedical Branch of the Shanghai European and American Alumni Association was held in Shanghai Pudong
More
Medicilon assists Cgenetech to accelerate the development of new anti-diabetic drugs
Dec 10,2019
Medicilon Co-organizes Shanghai European and American Alumni Association’s Biomedicine Year-end Meeting
Recently, Medicilon’s CMC preparations have developed another success. Amlodipine besylate tablets, a cardiovascular drug 289 base drug project developed for customers for lowering blood pressure,
More
Medicilon Co-organizes Shanghai European and American Alumni Association’s Biomedicine Year-end Meeting
Nov 27,2019
Happy Thanksgiving!
Medicilon wishes you and your family a Happy Thanksgiving Day!
More
Happy Thanksgiving!
Nov 06,2019
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China On Nov. 5th 2019, Shanghai Medicilon Inc. (Medicilon) announced an IPO on
More
Medicilon Inc. – Announcement of an IPO on Sci-Tech Innovation Board in China
Sep 27,2019
Medicilon will participate in SAPA-NJ Annual Conference 2019
sapa national conference 2019 SAPA-NJ Annual Conference will take place in Somerset, NJ on Sept 27-28, 2019.  Sino-American Pharmaceutical Professionals Association (SAPA) , founded in 1993,
More
Medicilon will participate in SAPA-NJ Annual Conference 2019
Sep 05,2019
Medicilon successfully exhibited in the ACS Meeting at San Diego
Medicilon successfully exhibit in the ACS Fall 2019 National Meeting which was held in San Diego on August 25-29.  Dr. Xingquan Ma, VP of Chemistry,
More
Medicilon successfully exhibited in the ACS Meeting at San Diego
Aug 30,2019
Medicilon's Differentiated Competitive Tactics Makes CRO Industry Chain "Small But Beautiful"
On August 27, 2019, the seminar on Preclinical Research of Innovative Drugs hosted by Shanghai Medicilon Inc. was successfully held in Beijing. 
More
Medicilon's Differentiated Competitive Tactics Makes CRO Industry Chain
Aug 29,2019
The Preclinical Research of Innovative Drug Seminar was successfully held in Beijing
On August 16-19, 2019, sponsored by the Chinese Pharmaceutical Association Drug Safety Evaluation and Research Committee, China Food and Drug Control Research Institute, Shanghai Medicilon
More
The Preclinical Research of Innovative Drug Seminar was successfully held in Beijing
Aug 22,2019
Medicilon successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director
On August 16-19, 2019, Shanghai Medicilon Inc. successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director, which hosted
More
Medicilon successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director